Stay updated on Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Recruitment status was added to the page, and several help/navigation sections were introduced to aid engagement with the study. The Intervention/Treatment labeling appears to have been reformatted, and the site revision note was updated to v3.6.0 (replacing v3.5.5).
    Difference
    0.2%
    Check dated 2026-06-15T18:40:03.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated from v3.5.4 to v3.5.5 on the page, signaling a minor update to the study record. This change reflects a non-substantive update to the page (likely metadata or UI adjustments) rather than edits to the study data or content.
    Difference
    0.0%
    Check dated 2026-06-08T15:12:31.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.5.4 now appears on the page, replacing Revision: v3.5.3. This indicates a site version update rather than a modification to the study information presented.
    Difference
    0.0%
    Check dated 2026-05-18T03:46:12.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page’s footer revision/version has been updated from **v3.5.0** to **v3.5.3**, reflecting a site release update without altering the study details.
    Difference
    0.0%
    Check dated 2026-04-26T15:34:29.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Replaced the study site entry Padua, Veneto, Italy, 35128 with Padova, Veneto, Italy, 35128. The city name is updated to the local spelling in the locations list.
    Difference
    0.0%
    Check dated 2026-04-05T06:56:17.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    The page adds a reference to Hepatocellular carcinoma and includes the Genetic and Rare Diseases Information Center as a resource. It also updates the page revision from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T20:14:54.000Z thumbnail image

Stay in the know with updates to Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial page.